FDA Approves Ella™ Tablets For Prescription Emergency Contraception : RushPRNews - Newswire & Global Press Release Distribution

 
Bookmark and Share

FDA Approves Ella™ Tablets For Prescription Emergency Contraception

August 16, 2010

FDA Approves Ella™ Tablets For Prescription Emergency Contraception
Washington, DC (RPRN) 08/16/10 — The U.S. Food and Drug Administration  approved ella™ (ulipristal acetate) tablets for emergency contraception. The prescription-only product prevents pregnancy when taken orally within 120 hours (five days) after a contraceptive failure or unprotected intercourse. It is not intended for routine use as a contraceptive.
 
ella is a progesterone agonist/antagonist whose likely main effect is to inhibit or delay ovulation. Since May 2009, the prescription product has been available in Europe under the brand name ellaOne.
 
An FDA Advisory Committee for Reproductive Health Drugs discussed ella in June, 2010. The committee unanimously voted that the application for ella provided compelling data on efficacy and sufficient information on safety for the proposed indication of emergency contraception.
 
The safety and efficacy of ella were demonstrated in two Phase III clinical trials. One study was a prospective, multi-center, open-label, single-arm trial conducted in the United States;
FDA Approves Ella™ Tablets For Prescription Emergency Contraception
FDA
the other was a randomized, multi-center, single-blind comparator-controlled trial conducted in the United States, United Kingdom and Ireland.  
 
Side effects most frequently observed with ella in the clinical trials include: headache, nausea, abdominal pain, pain/discomfort during menstruation (dysmenorrhea), fatigue, and dizziness. The profile of side effects for ella is similar to that of FDA-approved levonorgestrel emergency contraceptives.
 
According to the product’s labeling, women with known or suspected pregnancy and women who are breastfeeding should not use ella. A patient package insert also will be provided to ensure that women are fully informed of the benefits and risks involved in the use of ella.
 
ella is manufactured by Paris-based Laboratoire HRA Pharma. ella will be distributed by Watson Pharma Inc., of Morristown, N.J.
 
For more information:
 

ella Labeling Information

Editors note: Approved trade name is lower case ‘e.’

Media Contact Name: Elaine Gansz Bobo
Media E-mail:
Media Phone: 301-796-7567
Company Phone: 888-INFO-FDA
Main image credits: HRA Pharma
Body image credits: FDA
About the author:

FDA is an agency within the Department of Health and Human Services and consists of seven centers and offices

Click here to see all news from this author/company

Filed Under: BREAKING NEWS, FDA- Pharmaceutical news, Health and Fitness, Lifestyle, PRESS RELEASE

RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.

RSSFeed PRESS & SOCIAL MEDIA RELEASES

Newborn Foundation Co-Convenes Shanghai Symposium with Focus on Congenital Heart Disease in Newborns and Infants

Saint Paul, MN / Shanghai, China 10/20/14 · Expansion of Newborn Screening Program & Latest Data...

Ste. Anne's New Fitness Centre In An Idyllic Setting

GRAFTON, ONTARIO 10/17/14 · -Maison Sante is just one part of Ste. Anne's...

Newborn Foundation Honors Leaders in Newborn Health, Technology, Policy and Advocacy at 2014 Awards Gala

Minneapolis, MN 10/13/14 · – The Newborn Foundation, an international nonprofit leveraging...

Phaedra Beauty Cosmetics Re-Launches with New Packaging

Los Angeles, CA 10/13/14 · Hollywood celebrity make-up artist Phaedra L. Williams introduces...

Indie Film, The Ballad of Snake Oil Sam 2014 Global Film Festival Tour

Los Angeles, CA 10/13/14 · Indie Film, The Ballad of Snake Oil Sam...

Newborn Health & Technology Leader Dr. Terese Finitzo Receives ‘Eve Award’ for Innovation

MINNEAPOLIS, MN 10/10/14 · Newborn Foundation Awards Gala honors global leaders in...

Ste. Anne’s Spa: An Ideal Setting For Meeting And Team Building

Grafton, ON 10/08/14 · Ste. Anne’s Spa provides an ideal meeting environment,...

Renew Life Launches National TV Advertising Campaign with the help of Creative Bube Tube

Milton, ON 10/06/14 ·  - Renew Life proudly announces their latest marketing...

Black Travel Club Is Giving Away 1,000 Free Memberships – First come first served!

Atlanta, GA 10/01/14 · BlackTravelClub.com is inviting 1,000 people to join its...

Empirical Foresights is building EconKBase - An economic insights database (a non-profit initiative)

New York, NY 10/01/14 · The global research and adivsory firm Empirical Foresights...

Newborn Foundation Hosts 2014 Awards Gala

SAINT PAUL, MN 09/30/14 ·   Largest fundraiser of its kind will raise awareness...

Twenty dollars discount on your October press release submission order

SAN FRANCISCO 09/29/14 ·  Thank you for making September such a great...